Prof. Aristotelis Bamias, Peter Hoskin, Arnulf Stenzl
We have entered a new era wherein metastatic GU cancers can be associated with long-term survival without disease progression, and achievable cure. This is thanks to the close collaboration and involvement of diverse disciplines which are represented in EMUC congresses.
At EMUC21, we will also address current controversies and challenges such as the optimal utilization of diagnostic tools (including molecular markers) to personalise treatment approach and achieve maximum benefit for patients.
Expect lively and insightful deliberations during the sessions. We look forward to your participation during the discussions. In fact, we highly encourage it.